Director Annette L. Nazareth filed a Form 4 with the SEC on November 12, 2026, reporting the grant of 645 Deferred Stock Units and 2,659 stock options in Broadridge Financial Solutions, Inc. on November 10, 2026.

Key Highlights

  • DSU grant: Annette L. Nazareth received 645 Deferred Stock Units on November 10, 2026, at a price of $0.0000, under Broadridge's 2018 Omnibus Award Plan.
  • Vesting and settlement: According to the filing, the Deferred Stock Units "vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge."
  • Stock option grant: Nazareth also received 2,659 stock options (right to buy Common Stock) on November 10, 2026, at an exercise price of $192.96, expiring November 10, 2036.
  • Immediate vesting: The filing states that the stock options "vest immediately upon grant."
  • Post-transaction ownership: Following these transactions, Nazareth directly holds 10,479 shares of Common Stock and 2,659 derivative securities beneficially owned following the reported transaction.
  • Relationship to issuer: The filing identifies Nazareth solely as a Director of Broadridge Financial Solutions, Inc. (NYSE:BR).

Director Nazareth Receives Annual Equity Grants from Broadridge on November 10, 2026

According to the Form 4 filed on November 12, 2026, Director Annette L. Nazareth of Broadridge Financial Solutions, Inc. (NYSE:BR) received two equity awards on November 10, 2026. The first was a grant of 645 Deferred Stock Units (DSUs) classified as an acquisition (transaction code A) at a reported price of $0.0000. The filing notes these DSUs were granted "under Broadridge's 2018 Omnibus Award Plan" and represent "a like number of shares of Broadridge common stock."

The DSUs vest in full upon grant, the filing disclosed, but settlement into actual shares of Broadridge Common Stock occurs only upon the director's separation from service. Following this transaction, Nazareth's direct beneficial ownership of Common Stock stands at 10,479 shares, per the filing.

Separately, the filing reports that Nazareth also received 2,659 stock options (right to buy Common Stock) on November 10, 2026. These options carry an exercise price of $192.96 and expire on November 10, 2036. The filing states these options "vest immediately upon grant." Following the transaction, Nazareth directly holds 2,659 derivative securities. Both grants are recorded as direct ownership. The Form 4 was signed by Maria Allen under a Power of Attorney, dated November 12, 2026.

What Was Disclosed

Broadridge Financial Solutions director Annette L. Nazareth disclosed the receipt of 645 Deferred Stock Units and 2,659 immediately vesting stock options on November 10, 2026, bringing her direct Common Stock beneficial ownership to 10,479 shares following the DSU award.